# Olmutinib in T790M‐positive non–small cell lung cancer after failure of first‐line epidermal growth factor receptor‐tyrosine kinase inhibitor therapy: A global, phase 2 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/olmutinib-in-t790m-positive-non-small-cell-lung-cancer-after-failure-of-first/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Keunchil Park,Pasi A. Jänne,Dong‐Wan Kim,Ji‐Youn Han,Ming‐Fang Wu,Jong Seok Lee,Jin‐Hyoung Kang,Ki Hyeong Lee,Byoung Chul Cho,Chong‐Jen Yu,Yong Kek Pang,Enriqueta Felip,Hyunjin Kim,Eunhye Baek,Young Su Noh |
| Citations | 38 |
| DOI | 10.1002/cncr.33385 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1002/cncr.33385 |
| OpenAlex ID | https://openalex.org/W3121030351 |
| PMID | 33434335 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Yong Kek Pang](https://scholariq.org/researchers/yong-kek-pang/)

## Paper journal

- [Cancer](https://scholariq.org/journals/cancer/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.